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IGF-I binding and IGF-I mRNA expression in the post-
ischemic regenerating rat kidney
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IGF.I binding and IGF-L mRNA expression in the post.ischemic
regenerating rat kidney. The localization of IGF-l peptide and IGF-I
mRNA was investigated in the post-ischemic regenerating rat kidney
using immunohistochemistry and non-radioactive in situ hybridization
techniques. In addition, the distribution and relative quantity of IGF-l
binding sites were studied by autoradiographic ligand-binding tech-
niques. Two and three days after the injury, morphological signs of an
intense regenerative activity was evident. By this time a substantial
number of the regenerating cells were stained with a monoclonal
antibody against the Ml subunit of ribonucleotide reductase, a prolif.
erative marker used. Low proliferative tubular cells, replacing those
that had been injured, were seen lining the tubular basement membrane.
By seven days, the morphology in the cortex was quite normalized,
while cells of the S3 segments in the outer medulla remained dediffer-
entiated. The regenerative cells expressed IGF-l peptide and IGF-l
mRNA in a transient manner and this was found to correlate better to
cell differentiation than cell division, in addition, non-tubular cells,
predominantly macrophages, expressed both the IGF-I peptide and the
mRNA. The IGF-l binding was significantly increased in the regenera-
tive zone at all times studied and began to decline at day seven. The
binding characteristics were found to be compatible with binding to the
IGF-l receptor. Altogether, these findings provide circumstantial evi-
dence that IGF.i is of trophic importance in the regeneration of renal
tubular cells. The data are compatible with a local production and
action of LGF-I, suggesting an autocrine and/or paracrine mode of
action during the regenerative process.
The kidney possesses a remarkable capability of restoring its
structural and functional capacity after injury, regardless of
whether the injury was induced by circulatory disturbances or
by toxic agents [I, 2]. Depending upon the severity of the insult,
the renal epithelial cells seem to undergo various grades of
dedifferentiation until finally a certain limiting point is reached,
whereafter cell death occurs [3]. The susceptibility of the
various segments of the nephron to injury is rather specific, at
least following ischemic and hypoxic insults. In models of total
ischemia followed by reperfusion the proximal tubules, and
especially the straight portion, seems to suffer the most [2],
while in models of hypoxia combined with preserved circula-
tion, the straight part of the distal tubule is most vulnerable [4].
Even if specific foci exists concerning the distribution of
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cellular damage along the nephron all tubular cells will suffer
eventually if the ischemic period is sufficiently long.
Following injury, the necrotic cells are shed into the lumen
and an intense regenerative process follows. The present con-
cept suggests that surviving cells situated close to or within the
necrotic area dedifferentiate and enter mitotic cycles, and then
redifferentiate until the tissue is more or less completely re-
stored [2, 3]. The molecular basis regulating this regenerative
process is poorly understood, but some factors are known to be
prerequisites for an appropriate regeneration to occur. Perhaps
the most vital is the presence of an intact basement membrane
believed to serve as a frame for the regenerative cells, thereby
making sure the nephron integrity is reestablished [5]. An
additional factor vital for both the injury and the regenerative
response is the microcirculation in and close to the necrotic
area [6].
The dependence of renal tubular cells on peptide growth
factors during their growth and regeneration has been investi-
gated during recent years using various approaches with both in
vitro and in vivo studies [7—Il]. These studies indicate that the
growth of the tubular cells is under the control of a number of
peptide growth factors. At present, it seems reasonable to state
that two of them, insulin-like growth factor-I (IGF-I) and
epidermal growth factor (EGF) stand out as being of particular
interest, even though numerous other peptide growth factors
exert growth modulating functions on the renal epithelium [9,
11, 12].
In the normal kidney both EGF and IGF-I have been local-
ized to certain nephron segments using immunohistochemistry
[8, 13, 14]. For both peptides, recent in situ hybridisation
studies have shown that, under normal circumstances, cells
shown to express significant amounts of peptide coincides well
with the site of synthesis [15, 16]. During the post-ischemic
regeneration, however, this might not be the case. Both EGF
and IGF-I are expressed at the peptide level in other tubule cells
compared with where they are normally found during renal
regeneration [7, 17] but it has not been shown whether the
cellular expression of each peptide, under these circumstances,
is due to uptake, local synthesis or a combination of the two.
Studies on EGF, showing that exogenously administered EGF
can benefit the regeneration, may indicate that the immunore-
active EGF found in the regenerative zone is, at least partly, the
result of uptake from the circulation [10].
Peptide growth factors, including IGF-I, are known to medi-
ate their actions on target cells via interaction with receptors
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bound to the plasma membrane [18]. The regulation of receptor
density provides, in addition to ligand accessibility, an addi-
tional regulatory pathway. During compensatory growth and
diabetic renal growth, an up-regulation of IGF receptors has
been demonstrated, thereby implicating this phenomenon dur-
ing kidney growth [19, 20]. Whether this also is the case during
renal regeneration is the basis of the present study.
The kidneys were injured by means of warm ischemia fol-
lowed by reperfusion, and the regenerating kidneys were ex-
amined at predicted times.
Thus, the purpose of the present study on post-ischemic renal
regeneration was threefold: to determine whether the IGF-I
peptide expression among the regenerative cells is due to local
synthesis; to determine whether the regeneration is associated
with changes in IGF-I binding capacity; and to study the
relation between the expression of the Ml subunit of ribonu-
cleotide reductase (RR), a marker of cellular hyperplasia [21]
and IGF-I.
Methods
Animals
Young, adult male, Sprague-Dawley rats were used, weighing
approximately 200 g at the start of the experiments. They had
free access to food and water throughout the experimental
period.
Tissueprocessing and operational procedures
The animals were anaesthetized by an intraperitoneal injec-
tion of sodium pentobarbital (Mebumal®) 60 mg/kg body wt.
The left kidney was then exposed by a dorsolumbar incision
and, using a surgical microscope, the renal artery was exposed
and clamped. In addition, the renal capsule was dissected from
the rest of the kidney to avoid collateral circulation during the
ischemic period. Sham operated animals were subjected to all
of the above procedures except for clamping of the renal artery.
After 90 minutes of ischemia the artery clamp was removed, the
wounds were sutured and, following recovery, the animals were
returned to their cages.
For immunohistochemical studies, the animals were anaes-
thetized and then perfused transcardially with PBS followed by
a solution of 4% paraformaldehyde and 0.08% glutaraldehyde in
phosphate-buffered saline (PBS), pH 7.4. After fixation the left
kidney was removed, cut into thin slices, and immersion fixed
in the same fixative for another two hours. The tissue slices
were then cryoprotected for at least twelve hours before use in
7.5% sucrose in PBS at, pH 7.4.
For in situ hybridization studies, the animals were processed
basically according to a method described by Salido et al [161.
The animals were anesthetized and then fixed by transcardial
perfusion with 4% formaldehyde in phosphate buffered saline
(PBS), pH 7.4. The kidneys were removed, cut into thin slices,
and further immersion fixed in the same fixative for a total time
of 30 minutes. Thereafter, the slices were cryoprotected with
7.5% sucrose in PBS, pH 7.4 for 30 minutes, and then frozen in
isopentane chilled in liquid nitrogen and kept at —80°C until
further use.
For autoradiographic binding studies, the animals were
anaesthetized as above, the kidneys were rapidly removed, cut
into thin slices using a razor blade and immediately thereafter
fast frozen in isopentane chilled in liquid nitrogen and kept at
—80°C until used.
Light microscopy on plastic embedded tissue
One tissue slice was chosen from each animal for immuno-
histochemistry and was further immersion fixed for at least 12
hours. Thereafter, the sections were dehydrated and finally
embedded in metacrylate plastic using a Historesin embedding
kit (LKB, Sweden). After solidification, the I jsm sections were
cut on a microtome using glass knives. The sections were
stretched on a waterbath, collected and fastened to microscopic
slides. The sections were then stained with Richardssons stain
and mounted.
Immunohistochemisiry
Three animals were studied at each of the times two, three
and seven days after the injury. In addition, one animal at each
interval was sham operated and served as control. Eight mi-
crometer cryosections were cut using a cryostat and these were
fastened to gelatin-coated microscope slides.
For detection of IGF-I immunoreactivity, a polyclonal anti-
body (K 1792) was used, raised in rabbits towards the carboxy
terminal of human recombinant IGF-I. On Western blots the
antiserum recognizes purified IGF-I but not the structurally
related molecules, insulin, proinsulin and relaxin [22, 23]. In
competitive radioimmunoassays, the antiserum shows less than
5% cross reactivity with the closely related molecule, IGF-II
[221. After incubating the sections in 5% dried fat-free milk in
PBS for 30 minutes, the antibody was applied to sections in a
dilution of 1:1000 in the same solution overnight at +4°C.
Fig. 1. Sections from regenerating kidneys two days after ischemia. (a) One micrometer plastic section from the cortex. The tubule profiles are
distended and the cells lining the tubules are low and dedifferentiated. In the tubule lumina cellular debris and macrophages are observed
(arrowhead). Bar = 10 m. (b) One micrometer plastic section from the outer medullary region. The lumen of the tubule profile to the lower left
is totally obliterated by cellular debris (D). In the vessel in the center, entrapped white blood cells are seen. In the tubule profile to the right, the
basal membrane is focally denuded and some closely associated enlarged tubule cells with bizarre morphology are seen (arrows). Bar = 10 m.
(c) Cryosection incubated with the IUF-! antiserum K-1792. Most of the regenerating tubule cells are positive (open arrows). The cellular debris
in the tubule lumina stain negative but occasional cells in the lumina, presumably macrophages, show IGF-I-IR (arrowhead). Bar = 20 sm. (d)
Cryosection incubated with the monoclonal antivimentin antibody. Most of the regenerating tubule cells are positive. Note that the regenerative
cells expressing vimentin have a variable morphology. Some of them are large and bulge into the tubule lumen (curved bold arrows), while others
have a very slender appearance (open arrow). Note that the cellular debris in the tubule lumina is negative but vimentin expressing cells are
interspersed in the debris, presumably macrophages (straight bold arrow). Bar = 20 sm. (e) Cryosection incubated with the monoclonal
anti-ribonucleotide reductase antibody. A focal area with surviving uninjured tubules is seen in the upper part of the figure. The cells in these
tubules do not express RR. In the lower part of the figure some tubule profiles are seen with regenerating cells. Most of these cells express RR
and some of them are indicated with arrows. Due to endogenous peroxidase activity, the erythrocytes are also stained (arrowhead). Bar = 10 sm.
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Thereafter the sections were rinsed and incubated in species-
specific biotinylated F(ab')2 fragments (Amersham, UK) fol-
lowed by Streptavidin-horseradish peroxidase (HRP) (Amer-
sham) and then incubated in an diamino-benzidine solution.
Control sections were incubated with omission of the primary
antibody or with antiserum that had been preadsorbed to human
recombinant IGF-I, as previously described [7, 8].
Additional sections from each animal were stained with two
different monoclonal antibodies directed against the Ml subunit
of ribonucleotide reductase (RR) (In Ro Biomedtek) and the
intermediate filament vimentin (Dakopatts, Denmark). For
these monoclonal antibodies, the sections were preincubated
with 5% dried fat-free milk in PBS for 30 minutes, followed by
incubation with each antibody optimally diluted for 2 x 3
minutes in a Bio Rad microwave oven at 200 watts. The
sections were then rinsed in PBS and incubated with species
specific anti-mouse F(ab')2 fragments labeled with HRP (Am-
ersham). After an additional rinse the sections were incubated
in a DAB solution and finally mounted.
Probe and probe labeling
A 153 bp fragment of a genomic subclone of mouse IGF-I
(exon 3 by analogy to human IGF-I) subcloned into a pSP64
plasmid in opposite directions [24] was used as a template for
probe synthesis. The plasmid was linearized with EcoRI and
used as a template for IGF-I cRNA synthesis. Antisense and
sense strands were labeled by digoxigenin labeled-UTP using a
DIG RNA labeling kit (Boehringer Mannheim, Germany) ac-
cording to the manufacturer's instructions. The yield of labelled
RNA was quantitated by a dot blot dilution series towards the
standard supplied by the manufacturer.
In situ hybridization
For in situ hybridization two animals were studied at each
time interval. Ten micrometer cryosections were cut and
mounted on aminoalkylsaline-treated microscope slides [25].
The sections were dried and, thereafter, immersed in a 0.1 M
Tris-HC1 buffer at pH 8.0 which contained 50 mi EDTA. After
this, in order to reduce background staining, the sections were
extracted with a solution of chloroform/methanol (1:1) for five
minutes, and passed via 50% methanol back to PBS buffer
containing 2 pg glycine/mI (Sigma). The sections were then
placed in the same buffer containing 1 jsg/ml proteinase-K
(Sigma) for seven minutes at 37°C. The proteinase-K solution
had been predigested at 37°C for two hours. The sections were
then rinsed in PBS containing 2 sg/ml of glycine (Sigma)
followed by postfixation for 10 minutes in 4% paraformalde-
hyde. Thereafter the sections were rinsed in 2 pg glycine/mI
PBS and then in 0.2 SSC (I X SSC = 0.15 M NaC1 + 0.015 M
sodium citrate). The slides were drained and, without further
treatment, incubated in the hybridization solution containing 5
X SSC, 50% formamide and 10 sg tRNA (Boehringer Mann-
heim)/100 pi of solution. Each section was covered first with 20
pi of the hybridization solution containing a 15 ng probe per 10
p1 solution and then with small cover slips. Control sections
were incubated with the labeled sense strand at the same
concentration and hybridization was carried out at 45°C for 16
hours.
After hybridization, the cover slips were removed and,
subsequent to a short rinse in I x SSC, the sections were
treated with RNase A (20 sg/ml) (Boehringer Mannheim) in a
buffer containing 10 m'vi Tns, 0.5 M NaCI and 1 mM EDTA at
37°C for 30 minutes. These sections were then rinsed in the
same buffer but without the RNase for 30 minutes at room
temperature, followed by three changes of 0.1 SSC each for 20
minutes at 45°C. After equilibration in PBS at room tempera-
ture, they were incubated with a monoclonal anti-digoxigenin
antibody at a concentration of 10 g/ml PBS at pH 7.4 contain-
ing 5% dried fat-free milk in a microwave oven (HP 2500,
BioRad, England, UK) for 2 x 3 minutes, at 200 watts.
The sections were then rinsed three times in PBS and
incubated for 30 minutes at room temperature with a rabbit
anti-mouse immunoglobulin (Z4 12, Dakopatts, Denmark) di-
luted 1:50 in PBS. The antibody solution had been preadsorbed
to rat serum, 50 ml/p1 antibody solution, for one hour at room
temperature under constant shaking and briefly centrifuged
prior to incubation. The sections were once again washed three
times in PBS followed by incubation for 30 minutes in an
alkaline-anti-alkaline phosphatase (APAAP) complex (D 651,
Dakopatts, Denmark) diluted 1:50 in PBS. Once again the
sections were rinsed in PBS and incubation with the rabbit
anti-mouse immunoglobulin and the APAAP complex was
repeated in order to increase the sensitivity of the staining
reaction. After final washes in PBS, the sections were put in a
0.1 M Tris-HCI buffer containing 100 mmol/liter NaCI and 50
mmol/liter MgCl at pH 9.5. The sections were covered with the
same buffer containing 340 g/ml nitro blue tetrazolium salt
with 170 g/ml 5-bromo-4-chloro-3-indolyl phosphate toludium
salt as substrate and I m of levamizole to inhibit the endoge-
nous alkaline phosphatases. They were put in a damp chamber
at room temperature and developed in darkness for one to 12
hours. After completion of development, the sections were
washed in deionized water and mounted in a solution of
PBS:glycerol in the ratio of 1:9. A Zeiss photoscope was used
for micrographs of the sections.
Autoradiography
At least five animals were studied at each experimental
interval. In addition, seven animals were sham operated and
killed four days after the operation. These animals served as
controls for the experimental groups. Fourteen micrometer
cryosections were cut and mounted on gelatin-coated micro-
scope slides and allowed to dry at room temperature. [125I]
iodo-IGF-I, with a specific activity of 2000 Ci/mmol, was
purchased from Amersham. The labeled IGF-I was dissolved in
a Hepes buffer (25 mM Hepes, 140 ifiM NaC1, 5 mti KCI, 1.8 mM
CaCl) at pH 7.4 and containing 1% bovine serum albumin (BSA)
at a concentration of 0.1 n. Nonspecific binding was deter-
mined by adding 100 n of unlabeled IGF-I (provided by Kabi,
Stockholm, Sweden).
To further characterize the specificity of the ['25-I]-iodo-IGF-
I binding, the ability of porcine insulin to displace labeled IGF-I
from its binding site was investigated. In this set of experiments
I M of insulin was used to compete against the labeled IGF-I.
Each kidney section was incubated with 100 p1 ['25-I]-iodo-
IGF-I solution or with 100 p1 of tracer IGF-I, and then com-
peted with unlabeled IGF-I or insulin, respectively. Incubation
was performed for 20 hours at +4°C. The sections were rinsed
2 x 5 minutes in ice-cold Hepes buffer without BSA, followed
by 2 X 1 minute washes in cold deionized water. This was
Fig. 2. Sections from regenerating kidneys three days after ischemia. (a) One micrometer plastic section from the renal cortex from which a region
is shown which escaped injury. The proximal tubules (PT) have a normal appearance with slender microvilli on the cell surfaces. Bar = 10 m.
(b) One micrometer plastic section from the cortex. Regenerating tubules are seen lined with low epithelium. Cellular debris can be seen in the
tubule lumina. One tubule macrophage having a typically indented nucleus is indicated by an arrow. Some of the low regenerating cells express
microvilli on their surfaces identifying the tubules as proximal (arrowhead). Bar = 10 sm. (c) Cryosection processed for demonstration of IGF-1
mRNA. Many cells express IGF-I mRNA. In the regenerating tubules, the low cells covering the basal membrane are positive (open arrow). The
cellular debris in the tubule lumina is negative but one cell can be seen which express IGF-I mRNA positively, presumably a macrophage
(arrowhead). In some of the tubules, the IGF-I mRNA expression is only in sporadic cells (arrow). Bar = 30 sm. (d) Control section to (c)
incubated with the sense IGF-l cRNA. The tubule lumen is indicated for some of the tubules (L). Either no signal or only a very faint signal is seen.
Bar = 30 m. (e) Cryosection from a regenerative region processed for demonstration of IGF-l immunoreactivity. IGF-I-lR is seen in a collecting
duct (CD). In addition, low regenerating cells express IGF-I (open arrow). In a quite normalised tubule, probably proximal, one single cell
expresses IGF-I-IR (Arrowhead). Bar = 20 tm. (f) Cryosection from the cortex processed for demonstration of ribonucleotide reductase
immunoreactivity (RR-IR). The cells of the glomerular tuft do not express RR-IR (GL). However, most cells in the regenerating tubules express
RR-IR (arrows). The debris in the tubule lumina is negative. In addition, some interstitial cells express RR-IR (arrowhead). Bar = 20 m.
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followed by air drying at room temperature and exposure to
Hybond-3H-film (Amersham) for six days at —80°C. The films
were developed in D-19 developer (Kodak) for four minutes at
room temperature. Densitometric analyses were performed on
the films. In addition, photographs were made using the films as
negatives. Optical absorbances were measured for sections
incubated with labeled 1GF-I alone, and with labeled IGF-I
competed with unlabeled IGF-I or insulin. To determine the
specific binding the, optical densities were calculated for la-
beled IGF-I minus unlabeled IGF-I. In addition, to control that
binding of IGF-I was not due to binding of IGF-I to the insulin
receptor, optical densities were calculated for sections incu-
bated with labeled IGF-1 minus sections incubated with insulin.
Statistics
Statistical analyses were performed using one way analysis of
variance followed by Fischers protected, least significant dif-
ference test.
Results
Light microscopy on plastic sections
In animals examined two and three days after ischemia,
extensive areas that had been subjected to necrosis were seen
throughout the entire cortical area (Figs. Ia, b, and 2b) and,
while both proximal and distal tubules were injured the cortical
collecting ducts were less damaged. In addition, virtually all
proximal tubules were necrotic in the outer stripe of the outer
medulla (o.s.o.m.). In the cortex, small undamaged areas in
which the tubules showed normal morphology were inter-
spersed among the damaged ones (Fig. 2a). In the outer part of
the medulla there was extensive necrosis among the tubular
cells. In many of the necrotic tubules both in the cortex and in
the outer medulla, cellular debris was seen within the lumen.
Interspersed between this debris, macrophages were identified,
often loaded with phagocytic material (Figs. la and 2b). In the
peritubular and vascular spaces close to the necrotic tubules,
there was an infiltration of inflammatory cells, both macro-
phages and lymphocytes (Fig. lb). In the tubules that had been
subjected to injury, an intense regenerative activity was evident
among the surviving tubular cells. Mitotic figures were seen
especially on day 2 after ischemia, but they were evident also
on day 3. The regenerating cells showed considerable variabil-
ity in their morphology, some cells being small and slender and
with rudiment microvilli on their surface (Fig. 2b), others being
large and bulging in to the tubular lumina (Fig. ib). In the inner
medulla, hyalin aggregates were seen in the tubular system, but
the parenchymal cells appeared otherwise normal and seemed
largely unaffected by the injury.
Seven days after the injury the tubular system in the cortical
region had largely regained its normal morphology. The proxi-
mal tubules once again had normal slender microvilli on their
surfaces indicating that the regeneration was complete. Inter-
spersed among these normal tubules were distended tubular
profiles in which the epithelium was low and dedifferentiated.
The distension of the tubules suggested that this was due to
congestion at some distant site in the subpopulations of neph-
rons. In the outer stripe of the outer medulla, most of the
tubules still had a low and immature epithelium, suggesting that
the healing process in this region remained incomplete (Fig. 3a,
d, e). Some of the cells had rudimentary microvilli on their
surfaces identifying them as proximal tubule cells.
Immunohistochemistry
In normal animals IGF-I like immunoreactivity (IGF-I-IR)
was found as previously described in several studies [8, 13, 261,
in the collecting duct cells predominantly in the ducts situated
in the inner medulla but also in cells of the cortically located
collecting ducts. In addition, IGF-I-IR was found in cells
confined to the thin limb of Henle and to the glomerular tuft.
Staining for ribonucleotide reductase (RR), indicating cycling
cells, was very limited in sections from control animals, reflect-
ing the low cellular turnover in the renal epithelium during
normal circumstances. In normal kidneys staining for the fila-
ment vimentin was found in the interstitial cells and in the cells
of the glomerular tuft and blood vessels while all tubular cells
were negative. These findings confirm previous published re-
ports [27].
in regenerating kidneys, the IGF-I-IR was much more wide-
spread than in normal animals. Regenerating cells in the cortex
and outer stripe of the outer medulla, whether located in distal
or proximal tubules, showed IGF-I-IR in high numbers during
day 2 and 3 after the insult (Figs. Ic and 2e). Even though
numerous cells were labeled, specific labeling was seen at the
cellular level. Positive cells were situated adjacent to negative
ones (Figs. Ic and 2e). On these early days there was no clear
relation between cellular morphology and IGF-I-IR. Most la-
beled cells, however, were low and poorly differentiated,
although stained cells were also seen occasionally among the
more differentiated cells of proximal tubule origin.
In the tubular lumina some cells were labelled with the
vimentin antibody (Fig. id). These particular cells were inter-
preted as being macrophages. In addition dedifferentiated and
regenerating tubular cells expressed vimentin as did also nu-
merous interstitial cells (Fig. Id), again confirming results from
previous studies [27]. Macrophages located in the tubular
lumina sometimes showed IGF-I-IR (Fig. Ic). In contrast,
although often known to stain in an unspecific manner, the
debris was negative. At two and three days after the injury,
Fig. 3. Sections from regenerating kidneys seven days after ischemia. (a) One micrometer plastic section from the outer medulla. Tubule profiles
of the S3-segments are seen. Some of the cells have long slender microvilli and their is an abrupt transition to dedifferentiated cells (arrowheads).
Some debris and one macrophage is seen in the tubular lumen (open arrow). Bar = 10 m. (b) Cryosection processed for demonstration of IGF-I-IR
showing some normal cortical tubules that have recovered from injury. These tubules lack IGF-I-IR. Bar = 20 m. (c) Cryosection from healed
cortex processed for the demonstration of IGF-l mRNA. No specific hybridization is seen. Bar = 20 tm. (d) Cryosection from the outer medulla
processed for demonstration of IGF-l-lR and showing some distended tubule profiles with low epithelium expressing IGF-I-IR (arrows). Bar = 20
pm. (e) Sections from the outer medulla processed for the demonstration of IGF-I mRNA and showing distended tubular profiles lined with low
epithelium. These tubule cells express IGF-I mRNA (arrows). Bar = 20 m. (f) Cryosection processed for the demonstration of RR-IR. Some
distended and dedifferentjated tubules are shown (T). At this stage, no RR-IR can be demonstrated. The erythrocytes are labelled due to
endogenous peroxidase activity (arrows). Bar = 20 rm. (g) Cryosections processed for the demonstration of vimentin immunoreactivity.
Numerous cells in the interstitium are positive for vimentin. Cells confined to the normal tubules (NT) do not express vimentin, while the low
dedifferentiated cells in some of the tubule profiles exhibit positive reactivity (arrows). Bar = 20 m.
Fig. 4. Micrographs of renal cryosections processed for the demon-
stration of IGF-i binding sites, according to the description in Methods.
(a) The sections are incubated with labeled IGF-l alone. (b) A 1000-fold
excess unlabeled IGF-I competes with the labelled IGF-1. Thus, total
IGF-I binding is shown on the left and non-specific binding on right. The
difference in labeling represents the specific binding. (a) the upper
section is from an sham operated animal and shows conspicuous IGF-L
binding sites in the entire kidney. The lower section is from a kidney
three days after ischemia. The binding is increased in the cortical and
outer medullary region. (b) Serial sections of those sections seen in (a),
demonstrating that unlabeled IGF-I competes with IGF-I binding in all
regions of the kidney. Magnification x3.7.
04-
C
C,
I
24
Time, days
Fig. 5. The absorbency of the regenerative (A) and medullary (B),
regions, respectively. The upper curve in both diagrams represents the
specific IGF-I binding, i.e. fig 4b substracted from fig 4a. The lower
curve shows the amount of IGF-I binding competeable with 10,000-fold
excess of insulin. Each point on the curve represents the mean of at
least five individual sections. A. The upper curve shows an increase in
the IGF-I binding capacity in the regenerative zone at days two and
three after injury (**P < 0.01). The increase in IGF-1 binding begins to
decline on day seven but is still significantly elevated compared to
controls (* < 0.05). Furthermore, as shown in the lower curve excess
insulin is able to compete to some extent with IGF-l binding at all times
studied. Symbols are: (Lii) binding competition by IGF-L; (U) binding
competition by insulin. B. The upper curve illustrate the IGF-I binding
in the inner medulla. Note that, in the sham animals, the IGF-l binding
is higher in the inner medulla compared with in the cortex in (A). In the
inner medulla there is no difference in the IGF-I binding between
regenerating animals and sham operated controls. In addition, the lower
curve illustrates that excess insulin is able to compete to some extent
with the IGF.l binding.
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numerous cells in the tubular system were labelled with the RR
antibody, thereby identifying the cells as cycling (Figs. le and
20.
By seven days after the injury, the staining for IGF-I-IR (Fig.
3b) and RR largely had returned to a normal pattern in the
cortical area. Staining for IGF-I-IR was seen in some of the
collecting duct cells and in the glomerular tuft. In addition in
focal areas, distended tubules were seen with a low epithelium,
and showing IGF-I-IR. This IGF-I-IR seemed to be associated
with cellular dedifferentiation rather than proliferation, since
staining for RR was absent in these distended tubules. This
overall cortical pattern was in sharp contrast to that found in the
outer stripe of the outer medulla where the healing, as described
above, was less complete. In the outer stripe of the outer
medulla numerous flattened cells lining the basement membrane
were seen to have IGF-I-IR (Fig. 3d), and while comparable to
that found in the cortical region, they did not stain for RR (Fig.
30. These low tubular cells often stained with the intermediary
filament vimentin (Fig. 3g).
In the inner medulla no consistent change in the staining
intensity for IGF-I-IR was found in the present study.
in situ hybridization
In normal animals, the IGF-I mRNA was located as previ-
ously described [15], that is, positive staining was seen in
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medullary collecting ducts and occasionally in cells of the
glomerular tuft and the proximal tubules.
In animals studied two and three days after injury, numerous
regenerative cells stained for IGF-I mRNA in the cortical and
the outer medullary regions (Fig. 2c). The cellular distribution
of the staining was roughly the same as described for the
IGF-l-IR above, although whether the exact same cells were
labeled is unknown since double staining experiments were not
performed. In addition, some cells in the tubular lumen, pre-
sumably macrophages, expressed IGF-I mRNA (Fig. 2c). Small
cortical areas that had not been affected by the ischemia and,
therefore, had normal tubules were negative. In the collecting
duct cells in the inner medulla, there was a relatively faint
staining reaction compared to the proliferative cells in the
cortical region, suggesting a higher IGF-I mRNA content in the
latter cell population, Sections incubated with the control probe
were either negative or showed only faint background staining
(Fig. 2d).
Seven days after injury, the IGF-I mRNA content among
most of the fully regenerated cortical tubular cells was unde-
tectable and similar to normal animals (Fig. 3c). In contrast,
there were small areas of distended tubules having low epithe-
hum and still expressing IGF-I mRNA at detectable levels. As
for IGF-I-IR, there were numerous labeled cells in the still-not-
fully-recovered tubule cells of the outer stripe of the outer
medulla (Fig. 3e).
Autoradiography
In normal kidneys IGF-I binding sites were conspicuous in
the entire kidney (Figs. 4a, b, and 5a, b), confirming the findings
in previous studies [15]. In the regenerating kidneys, IGF-I
binding was increased compared to controls in the regenerating
cortex and outer medulla. Densitometric analyses showed the
IGF-I binding to be increased by some 70% on days two and
three, while the increased binding became less pronounced on
day seven (Fig. 5a). The IGF-l binding in the regenerating
kidneys was significantly increased at all times studied (Fig. 5a).
Furthermore, the labeled IGF-I was competitively reduced by
excess insulin although to a lesser extent, and there was no
significant change in the amount of IGF-I replaced by insulin in
experimental animals compared to controls (Fig. 5a).
The binding in the inner medulla was found to be higher than
in the cortex in sham operated animals (Figs. 4a and 5a, b).
However, in contrast to the cortex, there was no consistent
change in the medullary IGF-l binding during regeneration (Fig.
Sb).
Discussion
In the present study, we confirm and extend the findings of a
previous study on IGF-I-like immunoreactivity in the kidney in
relation to post-ischemic regeneration. In the previous study,
we used a shorter ischemic period and, as a consequence, the
injury and regeneration was most obvious in the highly vulner-
able S3-segments [2, 7]. In this study, we show that virtually all
regenerating tubule cells, independent of segment, are capable
of IGF-I expression when they recover from injury. By using in
situ hybridization, we could show that IGF-I mRNA is co-
localized with IGF-I peptide in these regenerating cells,
strongly suggesting that the immunostainable IGF-l, to a major
extent, originates in the regenerating cells themselves. Mitotic
cells were found in the regenerating tubules in high numbers on
days two and three after injury and, at the same time, most of
these cells expressed the proliferative marker RR. On day
seven, the proliferative activity was low as judged by these
criteria, albeit dedifferentiated tubule cells still expressed
IGF-I. In addition, the regeneration was found to be associated
with increased IGF-I binding in the regenerative zone, while the
binding in the more unaffected inner medulla was unaltered
compared with controls.
In a recent in vitro study on isolated proximal tubule cells,
the proliferative effects of various peptide growth factors was
investigated [9]. It was shown that EGF, in contrast to IGF-I,
was a strong mitogen for the tubule cells. Addition of IGF-I to
the cultures increased the thymidine incorporation index but
only at very high concentrations, and the maximal stimulation
was only a third of that found for EGF [9]. Consequently, this
study implies that, although IGF-I is capable of inducing cell
division in proximal tubule cells, this is not the main function of
IGF-I on these cells [9].
In a review article by Bacallo and Fine, it was suggested that
there exists a strong molecular and morphological relationship
between nephrogenesis and renal regeneration [3]. These au-
thors suggested that during regeneration "the integrity of the
epithelium is restored by re-establishing only those stages of
differentiation that have been lost and when cell death occurs,
mitogenesis in adjacent cells restores the continuity of the
epithelium and the entire sequence of differentiation events is
initiated in the newly regenerated cells". Having this hypothe-
sis as background, it is most interesting that Rogers and
colleagues in a recent study could show that IGF-I was of vital
importance for the growth and development of the premordial
metanephros in vitro, suggesting that IGF-l exerts vital actions
during nephrogenesis [28]. It can thus be argued that IGF-I is of
vital importance also for renal regeneration, a conclusion that
would be in line with the data presented in the present study.
A 50 to 70% increase in IGF-l binding was found in the
cortical regenerative zone. In the inner medulla, a region which
is quite resistant to injury, the IGF-I binding capacity was found
to be unaltered compared to controls. These findings are in line
with those of other studies [20] and indicate that up-regulation
in IGF-I binding is associated with renal growth and regenera-
tion, suggesting a causal relationship. However, the interpreta-
tion of radioligand binding studies on IGF-I is complicated by
several facts. The related receptors for IGF-I, IGF-H and
insulin all bind IGF-I, although with different affinities [18]. The
finding that insulin is capable of competing with radiolabeled
IGF-I for receptor binding, although less efficiently than unla-
beled LGF-I, allows some conclusions to be drawn. Insulin has
no affinity for the IGF-II receptor [181, and the fact that the
IGF-I binding is competitively reduced by insulin does exclude
the possibility that IGF-I binding is solely to the IGF-II recep-
tor. Furthermore, if the labeled IGF-I had been bound to insulin
receptors insulin would have been more efficient than unlabeled
IGF-I in the competitive studies. The opposite relation was
found in the present study. It is reasonable to conclude,
therefore, that the binding of IGF-l is to specific IGF-I binding
sites.
After establishing that the binding of labeled IGF-1 represents
specific IGF-l binding other complicating circumstances remain
to be elucidated. IGF-I binds not only to its own membrane
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receptor but also to IGF specific binding proteins (fGFBP).
Several such binding proteins have been described and they
cannot be readily discerned from IGF-I receptors on the basis
of competition experiments [181.
In a recent study is was shown that IGFBP was produced by
collecting duct cells [29] and it is also known that collecting duct
cells lack IGF-I receptors on their surface [261. Since the
collecting duct cells constitute the bulk of the tissue in the inner
medulla, it can be argued that the binding to this region
represents IGF-I binding to binding proteins and not to the
IGF-I receptors, or that the binding in the inner medulla
represents IGF-I binding to IGF-I receptors located on non-
collecting duct cells or, a combination of the two.
In normal animals, true IGF-I receptors have been located in
several cortical structures, including tubules [12]. As a conse-
quence, it is reasonable to assume that alterations in binding
capacity in this region reflects alterations in the density of IGF-I
receptors. Furthermore, it has been shown that, in the rat
kidney, changes in binding of '251-IGF-I to crude membrane
preparations are associated with similar changes in IGF-I
receptor mRNA, strongly suggesting that differences in IGF-I
binding, at least to some extent, reflects alterations in the
concentrations of IGF-I receptors [20].
In previous studies the localization and amount of binding of
'251-EGF to tissue sections of regenerating rat kidneys has been
investigated [30]. Interestingly, both the binding pattern and
time sequence for EGF binding in the initial regenerative phase
[30] does very much resemble what was found for IGF-I binding
in the present study. This similarity is likely to reflect that
tubule cells, during the regenerative process, are dependent on
a number of peptide growth factors for their growth and
differentiation.
The findings that most of the IGF-I found among the regen-
erative tubule cells originates from local synthesis and that the
receptor density is up-regulated on the same cell population
provides strong evidence that IGF-I, in this situation, exerts its
action in a paracrine or autocrine manner. In the normal kidney,
the predominant regulator of IGF-I production in the collecting
duct cells is growth hormone [31]. The factors regulating IGF-I
mRNA and peptide expression during regeneration are not
known, but studies using other experimental systems suggest
that the IGF-I synthesis during regeneration might be growth
hormone independent. In regenerating skeletal muscle, sub-
stances other than growth hormone regulate the IGF-I expres-
sion, both at the peptide and mRNA level [32]. IGF-I is
produced locally in the regenerating muscle both in hypophy-
sectomized and normal animals, thus excluding growth hor-
mone as the main regulator in this situation [32]. However, no
studies on regeneration in growth hormone-deficient animals
have been done in the kidney, but if one assumes that the same
conditions are valid for the kidney as for skeletal muscle, then
there must exist other substances, besides GH, that regulate
IGF-I. A strong candidate could be EGF, which is known to
both benefit renal regeneration [10] and regulate IGF-I expres-
sion in the renal tubule cells [33]. 'fhe precise mechanisms
involved in these complex interactions between various growth
factors and their regulatory substances during tubule growth are
only just beginning to be discerned.
In the present study macrophages were observed in the
regenerative zone, and in addition to their obvious phagocytic
activity, seem to express IGF-I at the peptide and mRNA level.
Macrophages have previously been shown to express IGF-I
during wound healing [34]. To what extent these cells promote
and modulate the regeneration remains to be shown but it seems
likely that, besides IGF-I, macrophages release other bioactive
molecules which act on the regenerative cells.
Cellular expression of the Ml subunit of ribonucleotide
reductase (RR) is a efficient marker for cycling cells [211.
Consequently, the histochemical studies on the expression of
RR in relation to various growth factors addresses the question
of whether or not a particular growth factor is temporally and
spatially coexpressed with dividing cells. As previously dis-
cussed, IGF-I appears to be a rather poor mitogen for tubule
cells grown in vitro [9]. This finding is in line with most
published studies on the relationship between the tissue content
of IGF-I and renal growth [8, 26]. These studies suggest that the
tissue content of IGF-I starts to rise first after the mitogenic
peak has reached its maximum, thereby making it less likely
that IGF-I is a strong mitogen. Since IGF-I, in the present
study, was expressed by dedifferentiated, non-cycling cells in
the later phase of the regenerative process, it is reasonable to
suggest that the expression of IGF-I, to some extent, is related
to cellular differentiation. On the other hand, it should be
emphasized that IGF-I exerts its actions on the tubule cells in a
highly complex micro-milieu composed of bioactive molecules
which may modulate the actions elicited by IGF-I. As a
consequence, the biological response elicited can be very
diverse and maybe diffuse in nature, since it likely depends on
the sum of the molecules acting on a specific cell. It has, for
instance, been shown in cell culture studies on renal epithelial
cells that the combination of insulin and hydrocortisone can be
involved in the control of both mitogenesis and hypertrophia,
the final outcome depending on the presence or absence of
transforming growth factor-a in the medium [35]. With this in
view, it might be that IGF-I actions change during the process
of regeneration due to differences in the micro-milieu surround-
ing the cells. Therefore, the more precise actions exerted by
IGF-I on the renal tissue during regeneration remains specula-
tive.
In conclusion, this study shows an induction of IGF-I syn-
thesis in rat kidney tubule cells recovering from ischemic
injury. In addition, the binding of iodinated IGF-I was increased
in the same region. Although the more precise role of IGF-I for
the course of renal regeneration awaits further studies, the data
are compatible with trophic actions mediated in a auto or
paracrine manner.
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